Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Isis and Merck & Co. establish collaboration for hepatitis C

June 15, 1998

Protein Design Labs' human antihepatitis B antibody enters phase IIa

June 12, 1998

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

June 11, 1998

First European clearance for Eisai's Pariet

June 11, 1998

Rebetron now available in the U.S.

June 9, 1998

Chinese herbal medicine reduces ALT levels in chronic hepatitis C

June 8, 1998

Zadaxin shows efficacy and safety in phase III trial for hepatitis B

June 8, 1998

Evaluation of rolipram in experimental animal models of colitis

June 5, 1998

FDA approves new combination therapy product for HCV

June 4, 1998

FDA advisory committee recommends approval of Avakine for Crohn's disease

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...